Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese HSK 1

Your complete learning platform for speakers of 21 languages: Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese.

By Bernd Sebastian Kamps and Andrea Melis

  Breast Cancer

  Free Subscription


Articles published in J Pathol

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    May 2026
  1. HIPOLITO A, Abreu B, Goncalves J, Silva F, et al
    Fatty acid and cysteine metabolic interplay regulate ferroptosis and highlight xCT as a selenium-chrysin target in breast carcinoma.
    J Pathol. 2026;269:34-54.
    PubMed     Abstract available


    April 2026
  2. LLEWELLYN AM, D'Costa SL, Lam CY, Gore JA, et al
    Topological analysis of the human lymph node reticular network predicts outcome in breast cancer.
    J Pathol. 2026 Apr 20. doi: 10.1002/path.70065.
    PubMed     Abstract available


    January 2026
  3. LI B, Zhong Y, Xing Z, Zhou J, et al
    Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays.
    J Pathol. 2026 Jan 26. doi: 10.1002/path.70028.
    PubMed     Abstract available


  4. LU X, Luo B, Wei Y, Zhang W, et al
    Integration of histopathological characteristics by machine learning improves the prediction of neoadjuvant immunochemotherapy response in triple-negative breast cancer.
    J Pathol. 2026 Jan 6. doi: 10.1002/path.70022.
    PubMed     Abstract available


  5. KADER T, Zethoven M, Mahale S, Saunders H, et al
    Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression.
    J Pathol. 2026;268:1-12.
    PubMed     Abstract available


  6. NTELIOPOULOS G, Wren E, Rushton A, Wadsley MK, et al
    Identification of actionable targets using DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded tissues followed by shallow whole-genome sequencing.
    J Pathol. 2026;268:13-26.
    PubMed     Abstract available


    December 2025
  7. RYAN L, Provenzano E, Grigoriadis A, Pinder SE, et al
    Issues and missed opportunities in lymph node assessment after neoadjuvant chemotherapy.
    J Pathol. 2025;267:374-384.
    PubMed     Abstract available


    November 2025
  8. LLINARES-BURGUET I, Sanoguera-Miralles L, Bueno-Martinez E, Garcia-Alvarez A, et al
    Generation of functional noncanonical donor splice sites by +2T variants in breast cancer susceptibility genes: impact on clinical interpretation.
    J Pathol. 2025 Nov 13. doi: 10.1002/path.6497.
    PubMed     Abstract available


    September 2025
  9. SIMPKINS C, Toska E
    Sparking malignancy: nicotine as a driver of stemness and metastasis in triple-negative breast cancer(dagger).
    J Pathol. 2025 Sep 9. doi: 10.1002/path.6475.
    PubMed     Abstract available


  10. LI W, He J, Li J, Xie X, et al
    High-fat diets influence breast cancer progression by modulating CAF-immune cell interactions through PLAT signaling.
    J Pathol. 2025 Sep 3. doi: 10.1002/path.6452.
    PubMed     Abstract available


    August 2025
  11. NGUYEN KA, McLemore LE, Ke Y, DePledge LN, et al
    Activation of PI3K and deletion of p53 in keratin 15-expressing mouse mammary cells induces tumor heterogeneity and plasticity modeling metaplastic breast cancer.
    J Pathol. 2025 Aug 13. doi: 10.1002/path.6463.
    PubMed     Abstract available


    April 2025
  12. KUO YC, Chen CL, Lee KL, Wang HF, et al
    Nicotine-driven enhancement of tumor malignancy in triple-negative breast cancer via additive regulation of CHRNA9 and IGF1R.
    J Pathol. 2025 Apr 17. doi: 10.1002/path.6423.
    PubMed     Abstract available


    March 2025
  13. DEFILIPPI P, Nigrelli F, Arina P, Taverna D, et al
    A breast cancer PDX collection enriched in luminal (ER(+)) tumors and young premenopausal patients to identify new therapeutic strategies for high-risk patients(dagger).
    J Pathol. 2025 Mar 27. doi: 10.1002/path.6418.
    PubMed     Abstract available


  14. RATZE MA, Enserink LN, Ishiyama N, van Kempen S, et al
    Afadin loss induces breast cancer metastasis through destabilisation of E-cadherin to F-actin linkage.
    J Pathol. 2025 Mar 3. doi: 10.1002/path.6394.
    PubMed     Abstract available


    January 2025
  15. LU X, Gou Z, Chen H, Li L, et al
    Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer.
    J Pathol. 2025 Jan 23. doi: 10.1002/path.6395.
    PubMed     Abstract available


    November 2024
  16. HATSE S, Lambrechts Y, Antoranz Martinez A, De Schepper M, et al
    Dissecting the immune infiltrate of primary luminal B-like breast carcinomas in relation to age.
    J Pathol. 2024;264:344-356.
    PubMed     Abstract available


    October 2024
  17. SEGATTO I, Mattevi MC, Rampioni Vinciguerra GL, Crestan N, et al
    A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.
    J Pathol. 2024 Oct 25. doi: 10.1002/path.6358.
    PubMed     Abstract available


    July 2024
  18. CARVALHO R, Santos L, Conde I, Leitao R, et al
    Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain.
    J Pathol. 2024 Jul 29. doi: 10.1002/path.6319.
    PubMed     Abstract available


  19. CHEN M, van den Tempel N, Bhattacharya A, Yu S, et al
    Functional ex vivo DNA fibre assay to measure replication dynamics in breast cancer tissue.
    J Pathol. 2024 Jul 18. doi: 10.1002/path.6328.
    PubMed     Abstract available


  20. HUTTEN SJ, Messal HA, Lips EH, Sheinman M, et al
    Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts.
    J Pathol. 2024;263:360-371.
    PubMed     Abstract available


    April 2024
  21. MEYER B, Stirzaker C, Ramkomuth S, Harvey K, et al
    Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
    J Pathol. 2024;262:480-494.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum